Important Deadlines
Meeting Summary
Antibodies are a mainstay as therapeutics, with emerging formats, combinations and innovative delivery methodologies promising to expand their reach across disease indications. This meeting will showcase trailblazing approaches in the design and engineering of novel biologic modalities as linked to their pre-clinical development and selected early outcomes in the clinic.
Specifically, the topics covered will engage discussions around:
1) antibody-based protein degraders,
2) next-generation antibody drug conjugate technologies
3) precision biologics
4) increasing accessibility of antibody drugs on a global scale
5) advances in combination biology and modalities
6) Fc domain engineering
In addition, two workshops will stimulate discussions around 1) an evolving landscape of regulatory considerations for new biologics, and 2) artificial-intelligence and machine-learning. These topics will draw from examples across medical indications, ranging from cancer to infectious diseases to autoimmune diseases and diseases of the central nervous system. Thus, this meeting will engage a vast audience, bring different arenas together within the antibody as drugs community and allow the field as a whole to challenge current paradigms and establish new research directions.
This conference is co-located with the Keystone Symposium on Drug Delivery to the Brain: Emerging Modalities to encourage cross-disciplinary insights and collaborations towards novel treatment modalities for brain diseases.
Meeting organizers Dr. Jean-Philippe Julien and Dr. Katherine Harris talk about why you should attend this meeting in the video below:
Still on the fence about registering? Check out the all-star lineup of speakers in the video below:
Unique Career Development Opportunities
This meeting will feature a Career Roundtable where trainees and early-career investigators will have the opportunity to interact with field leaders from across academic and industry sectors for essential career development advice and networking opportunities. Find out more about Career Roundtables here: https://www.keystonesymposia.org/diversity/career-development-initiatives
KEYSTONE SYMPOSIA THANKS OUR SPONSOR(S) FOR GENEROUSLY SUPPORTING THIS MEETING:
KEYSTONE SYMPOSIA THANKS THESE DONOR(S) FOR GENEROUSLY SUPPORTING THIS MEETING:
GRANT RECOGNITION:
Federal Funding provided by the National Institutes of Health:
Funding for this conference was made possible [in part] by 1R13AI188933-01 from the National Institute of Allergy and Infectious Diseases (NIAID). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
To access the NIH Safe Environment Policy, please click here.